There is “no further excuse to delay a digital regulatory infrastructure for medicines after the COVID-19 pandemic,” Medicines for Europe has declared in an open message to European heads of state and governments, calling for action to create a better co-ordinated regulatory framework for pharmaceuticals that will enable the region to better respond to future health crises.
[Sidebar#GB150589]





